Valpharma International SpA

Valpharma International SpA


Company description

Since more than 40 years, VALPHARMA has been specialized in the development and contract manufacture of modified release products in capsules (hard-soft) and tablets, with own technology, supplying them to pharmaceutical companies worldwide. Its own R&D Department develops annually many new products in modified release form with own patents, changing posology from three or more daily dosings into once-twice daily dosing, optimizing pharmaceutical effects and reducing side-effects. Authorized by the Italian, Brazilian, Iranian, Ivory Coast, Japanese, Turkish, Taiwanese and United Arab Emirates Health Authorities to manufacture pharmaceutical, nutraceutical, investigational medicinal products, controlled drugs and high potent drugs (sexual hormones). VALPHARMA has a close collaboration, open and transparent dialogue with pharmaceutical industries all over the world, including the most important multinationals, basing on signed agreements, with a manufacture of 1,7 billion doses/year and 300 products developed by our laboratories.

Quick facts

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Affiliated categories: Contract Manufacturing |Custom Manufacturing (general category) |Formulation development More

Upcoming events

13 oct 2020

CPhI Worldwide 2020

13 - 15 October 2020 Milan, Italy Visit us at stand 3J13 Book a meeting See our Exhibitor Profile   See full Exhibitor List

Recently at

5 nov 2019

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany We were at stand 90H30 See our Exhibitor Profile   See full Exhibitor List
Valpharma International SpA

Contact information




View all contact information